Expression of EGFRvIII in Thyroid Carcinoma: Immunohistochemical Study by Camel Antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of EGFRvIII in Thyroid Carcinoma: Immunohistochemical Study by Camel Antibodies

Published:2009-01 Issue:2 Volume:38 Page:165-180
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Omidfar Kobra,Moinfar Zahra,Sohi Alireza Naderi,Tavangar Seyed Mohamad,Haghpanah Vahid,Heshmat Ramin,Kashanian Soheila,Larijani Bagher

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1080/08820130902735998

Reference34 articles.

1. Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor, c‐erbB‐2 protein, estrogen receptor related protein, p21‐ras protein, and proliferation indicators in relation to tumor recurrences and patient survival

2. Immunohistochemical Detection of EGFRvIII in High Malignancy Grade Astrocytomas and Evaluation of Prognostic Significance

3. Efficient tumor targeting by single-domain antibody fragments of camels

4. Llama Single-Chain Antibody That Blocks Lipopolysaccharide Binding and Signaling: Prospects for Therapeutic Applications

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mini review on recent progress of microfluidic systems for antibody development;Journal of Diabetes & Metabolic Disorders;2024-01-18

2. Lateral Flow Assay: A Summary of Recent Progress for Improving Assay Performance;Biosensors;2023-08-23

3. A Sensitive Surface-Plasmon-Resonance (SPR)-Immunosensor Based on Multilayers of Graphene Oxide and Gold Nanoparticles for Epidermal Growth Factor Receptor Detection;IEEE Sensors Journal;2023-01-01

4. Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer;Cancer Cell International;2022-08-06

5. Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer;Cancer Cell International;2021-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3